Therapixel releases a new version of MammoScreen® that leverages prior exams for better accuracy
For the first time, an AI-based decision support software…
Therapixel announces close of 15 M€ series B financing to deploy MammoScreen® 2D/3D
The Company will accelerate the commercial deployment of…
Therapixel receives FDA clearance for use of its AI-based breast cancer screening software MammoScreen® on Digital Breast Tomosynthesis
AI-powered reading aid for screening 2D & 3D mammography…
Therapixel and RAD-AID International Announce Breast Imaging AI Collaboration for Global Health
The collaboration donates and supports AI for making breast…
Therapixel receives FDA 510(k) clearance for MammoScreen™
AI-powered reading aid for screening mammography improves…
Therapixel presents the results of its Reader study at the Virtual ECR 2020
Do not miss our research presentation (RPS 702-7) at the…
Therapixel to showcase its advanced AI for breast cancer screening at the Digital edition of ECR 2020
Visit our online booth to experience MammoScreen (Expo Hall…
Therapixel Founder & CSO will speak at RSNA Annual Meeting
Discover our award-winning AI-based algorithm at RSNA on…